Register
|
Login
Published News
Upcoming News
Submit a New Story
Blogs
Clinical Trials
Conferences & Events
Corporate
Financial
Product
Publications
Research & Development
RSS
2
Vote
Hazards of preemption - Did Johnson and Johnson fudge data for Evra patch?
Posted by
SMB
879 days ago (
http://scientific-misconduct.blogspot.com
)
Possible Fudged data, and shielding from lawsuits
Who Voted for this Story
SMB
worldpharmanews
Related Links
Patient Lawsuits Against Pharmacuetical Companies For Drug Injuries Might Be Prohibited In U.S.
Drug Injury Watch: Sprint Fidelis Recall Showed That FDA's Medical Device Safety System Is Flawed
Drug Injury Watch: Issue: Should We Be Prohibited From Filing Product Liability Lawsuits Against Medical Device Manufacturers And Pharmaceutical Companies?
Drug Injury Watch: Zyprexa And Diabetes: Is This A Tale Of Company Greed Coupled With FDA Failure?
Drug Injury Watch: Did You See Ortho-McNeil's Response To April 6 NYT Article About Ortho Evra And Federal Preemption?
Drug Injury Watch: Ortho Evra, Preemption, And The New York Times: Another Drug Company Response Letter
Drug Injury Watch: May 2008 Congressional Hearing On Federal Preemption Of Drug And Medical Device Lawsuits
Drug Injury Watch: Court's Riegel Preemption Ruling Would Be Negated With Bill Sponsored By Democrats In Congress
Drug Injury Watch: Newly Introduced Legislation Would Protect Legal Rights of Patients Harmed By Defective Medical Devices
Drug Injury Watch: Sprint Fidelis Litigation Update: 225 Lawsuits Filed In State Courts And Federal MDL As Of June 2008
Comments
Log in to comment
or register
here
.
Subscribe
Enter your email address:
Delivered by
FeedBurner
Top Users
Tag cloud
Live
Comments